OPHT Ophthotech Corporation

2.78
-0.12  -4%
Previous Close 2.90
Open 2.93
Price To book 0.00
Market Cap 99.67M
Shares 35,852,000
Volume 1,038,881
Short Ratio 7.42
Av. Daily Volume 762,825

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated 4Q 2016.
Zimura
Wet age-related macular degeneration (Wet-AMD)
Phase 3 data released December 12, 2016 - primary endpoint not met.
Fovista
Wet age-related macular degeneration (Wet-AMD)
Phase 2/3 trial initiated January 2016. Continues to enroll as of February 2017.
Zimura
Geographic atrophy

Latest News

  1. Why Is Ophthotech (OPHT) Down 13.7% Since the Last Earnings Report?
  2. Edited Transcript of OPHT earnings conference call or presentation 3-May-17 12:00pm GMT
  3. Newman Ferrara LLP Announces Corporate Governance Investigation of Ophthotech Corp. - OPHT
  4. Ophthotech (OPHT) Q1 Loss Narrower than Expected, Sales Miss
  5. Ophthotech reports 1Q loss
  6. Ophthotech Reports First Quarter 2017 Financial and Operating Results
  7. Investor Network: Ophthotech Corp. to Host Earnings Call
  8. ETFs with exposure to Ophthotech Corp. : May 1, 2017
  9. Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017
  10. Ophthotech Announces Leadership Transition Effective July 1, 2017
  11. ETFs with exposure to Ophthotech Corp. : April 7, 2017
  12. Ophthotech (OPHT) Down 2.9% Since Earnings Report: Can It Rebound?
  13. ETFs with exposure to Ophthotech Corp. : March 27, 2017
  14. Ophthotech Corp. :OPHT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  15. Ophthotech Corp. :OPHT-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
  16. OPHTHOTECH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Ophthotech Corporation – (OPHT)
  17. EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm
  18. INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm